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Scientiﬁc Article
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Abstract
Purpose: Treatment planning of skull based meningiomas can be difﬁcult due to the irregular shaped target volumes and proximity to
critical optic structures. This study evaluated the use of HyperArc (HA) radiosurgery optimization and delivery in conjunction with
multicriteria optimization (MCO) to create conformal and efﬁcient treatment plans for conventionally fractionated radiation therapy to
difﬁcult base-of-skull (BOS) lesions.
Methods and Materials: Twelve patients with BOS meningioma were retrospectively planned with HA-speciﬁc optimization algorithm,
stereotactic normal tissue objective (SRS-NTO), and conventional automatic normal tissue objective to evaluate normal brain sparing
(mean dose and V20 Gy). MCO was used on both SRS-NTO and automatic normal tissue objective plans to further decrease organ-atrisk doses and target dose maximum to within clinically acceptable constraints. Delivery efﬁciency was evaluated based on planned
monitor units.
Results: The SRS-NTO in HA can be used to improve the mid- and low-dose spread to normal brain tissue in the irradiation of BOS
meningiomas. Improvement in normal brain sparing can be seen in larger, more irregular shaped lesions and less so in smaller spherical
targets. MCO can be used in conjunction with the SRS-NTO to reduce target dose maximum and dose to organ at risk without
sacriﬁcing the gain in normal brain sparing.
Conclusions: HA can be beneﬁcial both in treatment planning by using the SRS-NTO and in delivery efﬁciency through the decrease in
monitor units and automated delivery.
Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NCND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Base-of-skull (BOS) meningiomas account for nearly
35% to 50% of all intracranial meningiomas.1 The extent
of surgical resection is a prognostic factor of progression
free survival rates; however, the challenge of resecting
BOS meningiomas using microsurgical techniques is the
proximity to cranial nerves II-VI, brain stem, and the
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internal carotid arteries. In the 1990s, stereotactic radiosurgery (SRS) became an alternative treatment method,
either as primary or adjuvant therapy for BOS lesions
with similar 5-year tumor control rates and less morbidity
than surgery.2-4 In the 2000s, improvements in magnetic
resonance imaging (MRI), image guided radiation therapy, and intensity modulated radiation therapy (IMRT),
established radiation therapy (RT) as an effective method
of managing BOS meningioma.
Hypo-fractionated stereotactic radiation therapy
(hFSRT), in 5 to 10 fractions, or fractionated stereotactic
radiation therapy (FSRT), in greater than 10 fractions, are
techniques used when use of SRS may be prohibitive
owing to tumor size, location adjacent to critical organs at
risk (OARs), or other logistical reasons (such as inability
of patient to lie supine for treatment duration). FSRT and
hFSRT combine the precision of stereotactic immobilization and steep dose gradients while simultaneously
providing the beneﬁt of fractionation, allowing for normal
tissue repair. Studies comparing SRS, hFSRT, and FSRT
treatments for BOS meningiomas show no statistical
signiﬁcance in progression free survival and lower incidence of adverse effects using hFSRT and FSRT for
larger lesions.5-9 RT-related toxicities for large lesions
include increased risk of edema, radiation necrosis, clinical worsening of neurologic functions, and permanent
neurologic deﬁcits.10 The risk of secondary meningiomas
developing after RT is also a concern for younger, pediatric patients.11
RT methods for BOS lesions include protons; carbon
ions; and photons with conformal dynamic arc, tomotherapy, IMRT, and volumetric modulated arc therapy.12-15
Particle-based RT is known to better spare normal tissue
and OARs and is ideal for pediatric cases; however, photons are more readily available. Comparison of photon
planning and delivery techniques has shown that IMRT
achieves conformal dose distributions, whereas noncoplanar beams allow further sparing of normal tissues.16
HyperArc High Deﬁnition Radiotherapy (HA-HDRT)
(Varian Medical Systems, Palo Alto, CA) is a commercial
solution designed to improve plan quality and delivery
efﬁciency for noncoplanar intracranial radiosurgery. The
SRS normal tissue objective (SRS-NTO) in HyperArc
(HA) optimization is a radiosurgery algorithm that focuses on creating sharp dose gradients at the edges of the
target volume to decrease dose to surrounding normal
tissues. The SRS-NTO is designed to control dose fall-off
and dose bridging at the level of 17% of the prescription
dose. It differs from the automatic-NTO (AutoNTO) used
in conventional volumetric modulated arc therapy planning by using a set of spatially variant upper dose constraints that are weighted based on the size, shape, and
position relative to the target. The AutoNTO uses a cost
function that deﬁnes the shape of the dose fall-off, which
is controlled by a set of internal parameters that are
dynamically adapted during optimization.17
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A patient protection zone in the HA-HDRT workﬂow,
which incorporates the immobilization device, safely
places the isocenter allowing for automated delivery of
noncoplanar arcs with built-in clearance checks. These
tools are valuable in radiosurgery planning and delivery,
allowing for more consistent plan quality and avoidance
of potential collisions.18 Previous studies have shown the
efﬁcacy of HA-HDRT delivery for single isocenter radiosurgery of multiple lesions, as well as the ability to
further decrease moderate-to-low normal brain dose using
the SRS-NTO compared with conventional VMAT
planning.19,20
BOS target volumes frequently overlap OARs once
margins are added, which makes achieving both target
coverage and OAR sparing challenging. Optimization of
the overlap region is recommended in the NRG Oncology
Radiation Therapy Oncology Group 0539 study, a phase
II trial for RT of intermediate and high-risk meningiomas.21 The overlap between the planning target volume
(PTV) and planning OAR volume (PRV) is deﬁned as the
PTVPRV. The PTVPRV is optimized to receive as much of
the prescription dose as possible while maintaining OAR
max point dose (0.03 cm3) constraints. Another technique
is to use multicriteria optimization (MCO). MCO is used
in many ﬁelds to help make optimal decisions when
tradeoffs exist between 2 or more conﬂicting objectives.22
In treatment planning, MCO has been shown to be
useful in multiple disease sites such as intracranial, head
and neck, lung, and pancreas.23-25 The Eclipse MCO algorithm uses an epsilon constraint method to generate a
library of plans that cover the pareto surface. The user
navigates the pareto surface in the MCO tradeoff workspace by using slider bars that interactively display dose
tradeoffs.17,26 Previous studies used MCO to maximize
tradeoffs in cases with multiple OARs, decrease planning
time, supplement knowledge-based-model creation, and
allow physician navigation of best clinical tradeoffs.27,28
MCO has yet to be used in conjunction with SRS-NTO
to control tradeoffs between steep dose gradients and
target dose maximum. Tradeoff for highly conformal dose
distributions using the SRS-NTO in HA is a higher
maximum dose, which is carefully regulated to minimize
the risk of radiation necrosis. In this study, HA-HDRT
was applied to conventionally fractionated BOS meningiomas, using the SRS-NTO to decrease normal brain
dose, in conjunction with MCO to minimize hotspots
from HA-HDRT and dose to adjacent OARs.

Methods and Materials
Patient selection
Twelve patients previously treated at our institution with
BOS meningiomas were retrospectively replanned. All
patients were World Health Organization grade I; 6
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Figure 1 Patient immobilized in Encompass QFix SRS
Immobilization system (cyan and magenta) with “virtual goggles” structure (light green) to avoid irradiation of orbits. Arc
geometry shown with 2 180 coplanar arcs and 2 arcs with
couch rotation of 45 and 315 . (A color version of this ﬁgure is
available at https://doi.org/10.1016/j.adro.2021.100663.)

received subtotal or partial resection and the other 6 patients were not candidates for surgery owing to proximity
and involvement of the optic pathway. These patients were
speciﬁcally chosen due to the target volume located adjacent to 1 or more OARs. The gross target volume was
contoured based on gadolinium-contrast enhanced MRI; a
2-mm margin was used to create the PTV. The average
PTV volume was 38.02 cm3 (0.90-114.68 cm3). The
original plans were prescribed to either 52.2 or 54 Gy in 1.8
Gy fractions to the PTV depending on OAR constraints.
Patients were immobilized in the Encompass SRS
Immobilization System (QFix, Avondale, PA). The QFix
Encompass SRS system consists of a 2-piece clamshell
style mask attached to a U-shaped carbon ﬁber couch
insert. It is a prerequisite for HA-HDRT delivery because
the Encompass system is used to demarcate the patient
protection zone in the treatment planning system.
Contrast-enhanced computed tomography images were
obtained on a Philips Brilliance Big Bore CT scanner
(Philips, Best, Netherlands) with 1-mm slice thickness
and fused with the contrast-enhanced MR.

Plan setup and optimization
Treatment planning was performed in the Eclipse
Treatment Planning System v15.6 (Varian Medical Systems, Palo Alto, CA) on an EDGE linear accelerator
(Varian Medical Systems) equipped with a high-deﬁnition
multileaf-collimator. Plans were optimized using the 6
MV ﬂattened beam with a maximum dose rate of 600
MU/min and calculated with the default HA grid size of
1.25 mm. The HA template includes 2 180 coplanar arcs
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and 3 additional noncoplanar arcs with couch rotations of
45, 315, and 90 or 270. For predominantly left or right
sided disease, only 3 arcs were used with couch kicks of
0 and 45 or 315, whereas when the lesion was located
more midline, an additional vertex (couch 90/270 ) was
added to the 3-arc beam arrangement.
HA-speciﬁc optimization algorithms used were the
collimator angle optimization algorithm and SRS-NTO.
The collimator angle optimization algorithm optimizes the
collimator angles to reduce the dose to the normal brain;
the optimized collimator angles from the HA plan were
used for all plans so that beam geometry remained the
same. Furthermore, “virtual goggles” were created to
protect the optic structures. A no beam entry rule was
placed on this structure during optimization to avoid beams
entering through the anterior optic pathways (see Fig 1).
Plans were replanned to 54 Gy and normalized so 95%
of the PTV received 100% of the prescription dose. No
optimization structures were used, because MCO was
used to determine the tradeoffs between PTV and OAR.
In addition, no margins were used on OARs. During
optimization, equivalent priorities were used for the NTO
and PTV (100); OARs used priorities of less weight (20).
In the MCO tradeoff workspace, 3 tradeoff objectives
were chosen for the PTV: an upper and lower objective to
0% and 100% of the target volume, respectively, as well
as a homogeneity objective. The homogeneity objective
assists in maintaining coverage to the target volume while
minimizing the hot spot. Upper point objectives to 0% of
the OARs (brain stem, chiasm, optic nerves) were used. In
the tradeoff workspace, the priority was to achieve the
OAR objectives. After OAR goals were achieved, the
OAR tradeoffs were locked before navigating to the best
PTV coverage and homogeneity. To compare the effects
of the SRS-NTO to the Auto-NTO, the MCO process was
repeated for the AutoNTO. Four optimized plans were
created for each patient: a HA plan using the HA-speciﬁc
algorithms, a HAMCO plan using the HA plan as the base
plan for MCO optimization, an AutoNTO plan using the
AutoNTO, and an AutoNTOMCO plan using the
AutoNTO plan as a base plan for MCO optimization.

Dosimetric comparison
All plans were normalized to achieve the same PTV
coverage to 95% of the PTV volume (PTVD95%). The
doses to 99% and 1% of the PTV (PTVD99% and
PTVD1%) were evaluated. Maximum point dose to the
OARs (D0.035cc) was evaluated to ensure all plans met
clinical dose constraints and did not differ signiﬁcantly in
each plan. The normal brain volume (Brain-PTV-Brainstem) receiving 20 Gy (NBrainV20Gy) and the mean
dose (NBrainmean) were evaluated. Conformality of the
high-dose region was evaluated using the Paddick conformity index (CI), and the low-dose region was
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Results

OARs and indices used in plan evaluation

Planning objectives
OAR

Volume (cm3)

Dose

Optic nerves and chiasm
Brainstem

0.035
0.035

54
54

Evaluation index
Index

Description

Normal brain (Brain e Mean dose to
PTV e Brainstem)
normal brain
Volume of normal
brain receiving
20 Gy
Paddick conformity
TV2RI
index
TV  V100%Rx
V50%Rx
Gradient index
V100%Rx

Abbreviation
NBrainmean
NBrainV20Gy

CIPaddick
GI

Abbreviations: OAR Z organs at risk; PTV Z planning target
volume; TV Z volume of target; TVRI Z volume of target covered
by the prescribed isodose line; V050%Rx Z volume of 50% prescription isodose; V100%Rx Z volume of 100% prescription isodose.

evaluated with the gradient index. Table 1 summarizes the
evaluated OARs and indices.

Plan delivery and efﬁciency
To verify plan deliverability, plans were delivered and
measured on the electronic portal imaging device. Using
the portal dose image prediction algorithm, the calculated
photon ﬂuence was compared with the ﬂuence delivered
on the Varian amorphous silicon (aSi-1200) detector.29
Gamma analysis was performed for each beam as well
as the plan composite using a gamma passing criteria of
2% dose and 2 mm distance to agreement. Finally, to
evaluate efﬁciency of delivery with HA automation, the
monitor units (MU) were compared.

Table 2

Dosimetric comparison
Table 2 summarizes the doses to the target volume
and OARs. Target hot spot, PTVD1%, was greater for
the HA plans using the SRS-NTO compared with
AutoNTO (P Z .003). For SRS-NTO and AutoNTO
plans, the addition of MCO increased target coverage
(PTVD99%) and decreased PTVD1% to achieve similar
plan qualities. Compared with the AutoNTO, the SRSNTO decreased both the NBrainmean and NBrainV20Gy
without MCO (P Z .0002, .0007) and with MCO (P Z
.001, .003). Figure 2a shows dose distributions and
dose volume histograms (Fig 2b) from the 4 plans
demonstrating the change in NBrainV20Gy. The
NBrainV20Gy increased in HAMCO compared with HA
plans on average by 10.16 cm3 and in AutoNTOMCO
compared with AutoNTO plans by 3.0 cm3. HAMCO
plans spared an additional 24 cm3 of NBrainV20Gy
compared with AutoNTOMCO plans. Although not
typically evaluated, low doses to serial structures such
as the optic pathway also showed a decrease in the HA
plans using the SRS-NTO compared with AutoNTO
plans, which can be observed in the shape of the dose
volume histograms.
The sparing of NBrainV20Gy (AutoNTOMCO HAMCO) ranged from 0.97 to 66 cm3. Due to the concavity of the volumes at the BOS and proximity to
OARs, the change in NBrainV20Gy between AutoNTOMCO and HAMCO plans was compared with PTV
sphericity (Fig 3). Sphericity quantiﬁes how compact
and similar an object is to a sphere, where a sphere has a
sphericity of 1. The sphericity is calculated as the ratio
of the surface area of a sphere with the same volume as
the object to the surface area of the object. Sparing of
greater than 20 cm3 of NormBrainV20Gy occurred for
PTV sphericity <0.85.

Summary of DVH results of PTV coverage and organ-at-risk sparing showing average values  standard deviation

Structure

Parameter

HA

HAMCO

AutoNTO

AutoNTOMCO

PTV

PTVD99% (Gy)
PTVD1% (Gy)
CIPaddick
GI
D0.035 cm3 (Gy)
D0.035 cm3 (Gy)
D0.035 cm3 (Gy)
D0.035 cm3 (Gy)
NBrainMean (Gy)
NBrainV20Gy (cc)
Monitor units (MU)

52.52  0.62
64.60  3.10
0.85  0.06
2.86  0.59
54.93  2.67
44.23  15.50
38.36  18.81
40.89  19.24
5.95  2.42
47.96  26.95
742  165

52.99  0.48
57.37  1.50
0.80  0.08
3.14  0.63
52.06  1.42
43.40  16.50
34.61  18.50
38.14  17.86
6.42  2.63
58.12  33.11
885  179

53.04  0.37
61.41  1.65
0.82  0.05
3.61  1.04
52.32  2.34
46.42  13.92
37.10  17.28
40.67  15.69
7.20  3.046
79.13  48.27
1307  383

53.11  0.42
58.08  1.66
0.79  0.06
3.54  0.80
52.40  0.89
44.10  15.77
35.24  18.49
39.75  16.46
7.32  3.16
82.13  50.75
1269  438

Optic chiasm
Brainstem
OpticNerve(L)
OpticNerve(R)
Normal brain

Abbreviations: CI Z conformity index; DVH Z dose volume histogram; GI Z gradient index; HA Z HyperArc; MCO Z multicriteria optimization; NTO Z normal tissue objective; PTV Z planning target volume.
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Figure 2 (a) Prescription dose (blue), mid-dose 43.2 Gy (cyan), and V20 Gy (light green). Note changes in conformality between
upper and lower images with the addition of multicriteria optimization (MCO), with tradeoffs in normal brain dose. (b) Dose volume
histogram (DVH) of planning target volume (PTV) (magenta), OpticNerve(L) (orange), OpticNerve(R) (red), Normal Brain (blue), and
Brainstem (yellow). (A color version of this ﬁgure is available at https://doi.org/10.1016/j.adro.2021.100663.)
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Figure 3 Change in normal brain volume receiving 20 Gy (NBrainV20Gy) between automatic-normal tissue objective multicriteria
optimization (AutoNTOMCO) and HyperArc (HA)MCO compared with planning target volume (PTV) and sphericity.

For OARs, neither SRS-NTO nor AutoNTO plans
resulted in greater OAR doses. After MCO, all OAR
objectives were met with no signiﬁcant difference. The
tradeoff in achieving OAR tolerance can be observed in
the decrease in the CIPaddick. HA and AutoNTO both have
better conformality than their MCO counterparts (P Z
.002). After MCO optimization, both plans achieved
similar conformality with no statistical difference (P >
.05). The GIs of HA compared with AutoNTO plans were
signiﬁcantly better before MCO (P Z .0003) as well as
after MCO (P Z .0004).

Deliverability and quality assurance
The HA plan used an average of 742 MUs whereas the
AutoNTO plan required nearly double the MUs (Table 2).
The MUs for the MCO plans increased on average by 146
MUs for the HAMCO plans but decreased by 38 MUs for
the AutoNTOMCO plans.
The average plan composite gamma pass rate for the
HA, HAMCO, AutoNTO, and AutoNTOMCO plans was
99.5%. HA plans had the lowest plan composite pass rate
of 98.1%. Per beam, no signiﬁcant differences were
observed between HA and AutoNTO plan delivery results. However, a slight decrease in per beam gamma pass
rate was observed in the HAMCO compared with HA plans
(P Z .04).

Discussion
One risk of treating benign meningiomas with radiation is the risk of secondary malignancy and damage to
normal brain and OARs. The risk of developing a

meningioma after cranial irradiation was reviewed by
Strojan et al,11 with concern that irradiation of neighboring meninges would increase risk of secondary meningiomas. Indications of increased risk include younger
age at presentation, a higher female:male ratio, and
atypical histology. The use of SRS-NTO in HA optimization would signiﬁcantly decrease the irradiated volume
of normal brain for large, irregular shaped lesions,
effectively lowering the inherent risk.
HA optimization algorithms not only have a dosimetric
beneﬁt, but the automated delivery of couch rotations in
the HA-HDRT workﬂow allows for additional patient
safety and treatment efﬁciency. For clinics that use
noncoplanar beams sparingly, this allows an additional
comfort level when clearance can be guaranteed before
patient treatment, whereas for clinics that use noncoplanar
beams frequently, automation of couch kicks assists in
treatment efﬁciency, allowing rotations to be applied from
the treatment console and no pause in treatment while
waiting for beam mode-up. From the evaluation of MUs,
the SRS-NTO HA optimizer converges to a more efﬁcient
solution compared with the AutoNTO.
Although delivery efﬁciency is increased when using
HA, the planning time increases with the addition of the
MCO library plan creation. The MCO algorithm creates
3n þ 1 plans for each objective, which can be time
consuming if there are many objectives. To improve the
efﬁciency, a new MCO feature available in v15.6 and
above is hybrid optimization. This allows for faster
calculation of the tradeoff plans using a hybrid IMRT
technique that uses the graphics processing unit for IMRT
optimization. HA-HDRT and MCO v15.6 does not allow
for hybrid optimization without removing HA-HDRT
delivery automation; automation cannot be added after

Advances in Radiation Oncology: JulyeAgust 2021

removal. Due to the beneﬁts in delivery automation for
HA plans, the hybrid optimization was not investigated in
the study. Future investigations into the cost beneﬁt in
efﬁciency of using hybrid optimization may be
performed.
The shortcoming of any planning study is the inherent
plan bias. Comparison to the original treated plans was
not performed owing to variability in use of noncoplanar
arcs that affects the low-dose distributions. Similarly,
owing to variability in planning techniques, some original
plans were unable to meet OAR constraints and thus were
not treated to 54 Gy. Although further investigation is
needed, preliminary results show that MCO can achieve
more consistent plan quality and perhaps allow for dose
escalation with high-grade tumors as in Radiation Therapy Oncology Group 0539. In the MCO tradeoffexploration space, the user controls slider bars where
small changes lead to large changes in the ﬁnal plan dose,
making the process extremely user-dependent. Furthermore, in the tradeoff-exploration space, dose visualized in
the workspace is not the ﬁnal dose distribution because
machine parameters and MLC motions need to be
accounted for in the dose calculation. This can lead to
slight changes in the target coverage and OAR sparing
between MCO plans. In this study, we used the best effort
to navigate to the same objectives in the tradeoff space
and verify that dose constraints were met after ﬁnal dose
calculation. Because there are multiple solutions in the
MCO space, the solution is user-dependent. It is not fair
to say that the plan evaluated was objectively the best
plan; however, it was optimized in a similar method for
both SRS-NTO and Auto-NTO. Further investigation is
warranted in exploring the MCO workspace to evaluate if
the plan quality can be further improved.

Conclusions
HA and MCO can be used to improve the mid- and
low-dose spread to normal brain tissue in the irradiation
of BOS meningiomas. Greater improvement in normal
brain sparing is seen in larger, more irregular shaped lesions and is less signiﬁcant in smaller spherical targets.
HA is beneﬁcial both in treatment planning by using the
SRS-NTO and in delivery efﬁciency through the decrease
in MUs and automated delivery.
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